Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

about

The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.

P2860

Q36832243-3B5D04D6-53CF-442C-8EEA-808A8BFCA0D0 Q41438064-FFDC2CEF-0D37-4696-BE00-B46251CB2A7F

P2860

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

Item

http://www.wikidata.org/entity/Q37372416

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

@en

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme.

@nl

type

Item

label

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

@en

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme.

@nl

prefLabel

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

@en

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme.

@nl

P1476

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

@en

P2093

Arun T Jacob

http://www.w3.org/2001/XMLSchema#string

Daniela A Bota

http://www.w3.org/2001/XMLSchema#string

Frank P K Hsu

http://www.w3.org/2001/XMLSchema#string

Joseph A Hanson

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor angiogenesis: therapeutic implications

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Angiogenesis as a therapeutic target

Tumorigenesis and the angiogenic switch

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Epidemiology and etiology of gliomas.

P304

68-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7812/TPP/13-081

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Alexandru

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24361023

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

3854812

http://www.w3.org/2001/XMLSchema#string

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

about

P2860

P2860

Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932